Ultralife (NASDAQ:ULBI) Stock Crosses Above 200 Day Moving Average of $8.33

Shares of Ultralife Co. (NASDAQ:ULBIGet Free Report) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $8.33 and traded as high as $13.39. Ultralife shares last traded at $12.66, with a volume of 106,955 shares trading hands.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on ULBI shares. StockNews.com lowered Ultralife from a “strong-buy” rating to a “buy” rating in a report on Thursday, May 2nd. Benchmark boosted their price target on Ultralife from $12.00 to $13.00 and gave the stock a “buy” rating in a research report on Tuesday, March 5th.

Read Our Latest Stock Report on ULBI

Ultralife Stock Down 3.1 %

The business’s fifty day moving average price is $9.79 and its two-hundred day moving average price is $8.33. The company has a debt-to-equity ratio of 0.18, a quick ratio of 2.16 and a current ratio of 4.03. The firm has a market capitalization of $208.47 million, a P/E ratio of 19.78 and a beta of 1.12.

Ultralife (NASDAQ:ULBIGet Free Report) last announced its earnings results on Thursday, February 15th. The technology company reported $0.18 earnings per share for the quarter. The company had revenue of $44.55 million during the quarter. Ultralife had a net margin of 6.19% and a return on equity of 10.31%.

Institutional Trading of Ultralife

Several large investors have recently bought and sold shares of ULBI. Empowered Funds LLC increased its position in shares of Ultralife by 7.8% in the 1st quarter. Empowered Funds LLC now owns 31,396 shares of the technology company’s stock valued at $277,000 after acquiring an additional 2,275 shares during the period. Janney Montgomery Scott LLC increased its holdings in shares of Ultralife by 10.0% in the first quarter. Janney Montgomery Scott LLC now owns 439,100 shares of the technology company’s stock valued at $3,868,000 after purchasing an additional 40,000 shares during the period. Visionary Wealth Advisors raised its stake in shares of Ultralife by 0.9% in the fourth quarter. Visionary Wealth Advisors now owns 1,082,246 shares of the technology company’s stock worth $7,381,000 after purchasing an additional 9,997 shares during the last quarter. D.A. Davidson & CO. acquired a new stake in shares of Ultralife during the fourth quarter worth about $163,000. Finally, Navellier & Associates Inc. acquired a new position in Ultralife in the 4th quarter worth approximately $310,000. Hedge funds and other institutional investors own 30.68% of the company’s stock.

About Ultralife

(Get Free Report)

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.

See Also

Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.